SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,801 | +9.4% | 3,605 | -0.8% | 0.00% | – |
| Q2 2023 | $699,207 | -94.3% | 3,633 | -94.0% | 0.00% | -100.0% |
| Q1 2023 | $12,295,598 | +188.6% | 60,728 | +83.0% | 0.01% | +133.3% |
| Q4 2022 | $4,261,086 | +16.2% | 33,189 | +23.0% | 0.00% | 0.0% |
| Q3 2022 | $3,666,765 | -42.7% | 26,985 | -24.6% | 0.00% | -25.0% |
| Q2 2022 | $6,398,751 | -15.2% | 35,789 | -32.7% | 0.00% | -20.0% |
| Q1 2022 | $7,543,662 | +1385.0% | 53,210 | +1544.3% | 0.01% | – |
| Q4 2021 | $508,000 | -16.4% | 3,236 | -9.7% | 0.00% | – |
| Q3 2021 | $608,000 | +7.4% | 3,582 | 0.0% | 0.00% | – |
| Q2 2021 | $566,000 | +13.9% | 3,582 | 0.0% | 0.00% | – |
| Q1 2021 | $497,000 | -20.7% | 3,582 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $627,000 | – | 3,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |